{"transactions":[{"id":1303483,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2025-01-14T21:15:20.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":8641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":54765,"source":{"system":"sec-edgar","filing":"0001493152-25-002147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225002147/ownership.xml","form_type":"4"}},{"id":1536214,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":false,"shares":64848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested in 7 equal monthly installments beginning on April 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2024-04-28","underlying":"Common Stock","underlying_shares":64848},"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1536213,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":29031,"price":2.58,"value":74899.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to cover the exercise price of the options exercised."}],"balance_after":46124,"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1536212,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":true,"shares":64848,"price":1.16,"value":75223.68,"ownership":{"direct":true},"balance_after":75155,"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1661804,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-02-02T21:25:13.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":6688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":10307,"source":{"system":"sec-edgar","filing":"0001493152-24-004768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224004768/ownership.xml","form_type":"4"}},{"id":2096208,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock, par value $0.007","published_at":"2022-12-05T21:29:20.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":3619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Zannes of 3,619 restricted shares of the Issuer's common stock, par value $0.007 (the \"Common Stock\"), on November 17, 2022 under the Issuer's 2014 Equity Incentive Plan. The restricted stock will begin vesting on December 17, 2022 in 12 monthly installments, the first 11 of which will be of 301 shares of Common Stock and the last of which will be of the remaining 308 shares of Common Stock, subject to Mr. Zannes's continuous service to the Issuer through each vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Zannes of 3,619 restricted shares of the Issuer's common stock, par value $0.007 (the \"Common Stock\"), on November 17, 2022 under the Issuer's 2014 Equity Incentive Plan. The restricted stock will begin vesting on December 17, 2022 in 12 monthly installments, the first 11 of which will be of 301 shares of Common Stock and the last of which will be of the remaining 308 shares of Common Stock, subject to Mr. Zannes's continuous service to the Issuer through each vesting date."}],"balance_after":3619,"source":{"system":"sec-edgar","filing":"0001493152-22-034472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034472/ownership.xml","form_type":"4"}}]}